Study: Immunotherapy Halts Insulin Destruction in Type 1 Diabetes – AJMC.com Managed Markets Network
|
Study: Immunotherapy Halts Insulin Destruction in Type 1 Diabetes
AJMC.com Managed Markets Network In a placebo-controlled trial of 27 patients, they found that patients who were within the first 100 days of T1D diagnosis could be treated every 2 to 4 weeks with proinsulin peptide immunotherapy, an approach that prior work suggested would avoid … |
